Structure and Function of Heme-based Dioxygenases
血红素双加氧酶的结构和功能
基本信息
- 批准号:10398107
- 负责人:
- 金额:$ 42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressBindingBinding SitesBiochemicalBiological ProcessBiophysicsClinicalClinical TreatmentClinical TrialsDataDioxygenasesDiseaseDrug Binding SiteDrug TargetingEnzymesEssential Amino AcidsExhibitsFamilyFundingGoalsGuidelinesHemeHumanKnowledgeKynurenineMalignant NeoplasmsMass Spectrum AnalysisMental DepressionMolecularNeurodegenerative DisordersOutcome StudyPathway interactionsPharmaceutical PreparationsPhysiologicalPhysiologyPropertyProtein IsoformsPublic HealthReactionRoleSiteStructureStructure-Activity RelationshipSulfamethoxazoleTechniquesTechnologyTestingTherapeuticTherapeutic InterventionTryptophanTryptophan 2,3 DioxygenaseTumor EscapeX-Ray Crystallographybasebiophysical techniquescancer cellcancer immunotherapydietarydisorder controldisorder preventiondrug developmentindoleamineinhibitorinnovationinsightmembernew therapeutic targetnovelrational designscreeningsmall moleculethree dimensional structure
项目摘要
SUMMARY
Tryptophan (Trp) is the least abundant essential amino acid. The majority of our dietary Trp is metabolized
through the kynurenine (KYN) pathway. The first and rate-limiting step of the KYN pathway is catalyzed by
three heme-based dioxygenases, tryptophan dioxygenase (hTDO), indoleamine 2,3-dioxygenase 1 (hIDO1), and
indoleamine 2,3-dioxygenase 2 (hIDO2). Recently it was found that the three dioxygenases are expressed in
cancer cells to promote cancer immune escape. Consequently they have been considered as key drug targets for
cancer immunotherapy. Despite their importance, the structural and functional properties of these enzymes remain
elusive, which has hindered the progress of the field. The central hypothesis of this project, as supported by our
preliminary data, is (i) the functional properties of the three dioxygenases are regulated by cellular metabolites
and (ii) each dioxygenase exhibits distinct structural features and possesses unique drug binding sites. We will
test our hypothesis by addressing two specific aims: (i) identify cellular metabolites that interact with each
dioxygenase and define the related regulatory mechanisms, and (ii) define structural differences between the three
dioxygenases and determine new small molecule binding sites in each dioxygenase. We will use a new high-
throughput mass spectrometry-based screening technology to identify metabolites that interact with each
dioxygenase and use X-ray crystallography and spectroscopic techniques to define their specific molecular
interactions and functional consequences. These studies will reveal previously unknown cellular players in
dioxygenase-related human physiology that may impact the specific functions of these enzymes in cancer and
other diseases, thereby offering novel information enabling innovative molecular approaches for disease
prevention and control. In parallel, we will use an integrated approach, involving a wide spectrum of biochemical
and biophysical techniques, and a group of structurally diverse inhibitors as probes to define unique structural
features and new small molecule binding sites in each dioxygenase. The outcome of these studies will offer
important knowledge enabling better understanding of structure-and-function relationships of the three heme-
based dioxygenases and expanding our toolkit for rational design of enzyme-selective inhibitors. We have
assembled a team of experts to carry out this innovative project with the multifaceted approach. These studies
will address significant gaps in our knowledge of molecular mechanisms underlying the biological functions of
the three dioxygenases and provide important new insights into related drug development and disease treatment.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Syun-Ru Yeh其他文献
Syun-Ru Yeh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Syun-Ru Yeh', 18)}}的其他基金
Expanding the Catalytic Repertoire of Heme-based Dioxygenases
扩展血红素双加氧酶的催化能力
- 批准号:
10719622 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Structure and Function of Heme-based Dioxygenases
血红素双加氧酶的结构和功能
- 批准号:
10614501 - 财政年份:2016
- 资助金额:
$ 42万 - 项目类别:
Catalytic and regulatory mechanisms of human Tryptophan Dioxygenase
人色氨酸双加氧酶的催化和调节机制
- 批准号:
9107183 - 财政年份:2016
- 资助金额:
$ 42万 - 项目类别:
Catalytic and Inhibitory Mechanisms in Indoleamine 2,3-dioxygenase
吲哚胺 2,3-双加氧酶的催化和抑制机制
- 批准号:
8257584 - 财政年份:2010
- 资助金额:
$ 42万 - 项目类别:
Catalytic and Inhibitory Mechanisms in Indoleamine 2,3-dioxygenase
吲哚胺 2,3-双加氧酶的催化和抑制机制
- 批准号:
7889844 - 财政年份:2010
- 资助金额:
$ 42万 - 项目类别:
Catalytic and Inhibitory Mechanisms in Indoleamine 2,3-dioxygenase
吲哚胺 2,3-双加氧酶的催化和抑制机制
- 批准号:
8078881 - 财政年份:2010
- 资助金额:
$ 42万 - 项目类别:
Catalytic and Inhibitory Mechanisms in Indoleamine 2,3-dioxygenase
吲哚胺 2,3-双加氧酶的催化和抑制机制
- 批准号:
8451545 - 财政年份:2010
- 资助金额:
$ 42万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 42万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 42万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 42万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 42万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 42万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 42万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 42万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 42万 - 项目类别:
Standard Grant














{{item.name}}会员




